HOME >> MEDICINE >> NEWS
New cancer classification brings quicker treatment to some

COLUMBUS, Ohio - An international group of cancer specialists has developed a new classification for cancers of the blood that in some cases will change when treatment will begin and what treatment will be received.

The physicians have worked five years to develop the new classification system, which will be used by the World Health Organization.

"The changes aren't just cosmetic -- they will improve how some cancers are treated," said Clara Bloomfield, director of Ohio State University's Comprehensive Cancer Center. For example, the number of abnormal cells that must be present in the diagnosis of acute myeloid leukemia (AML) versus myelodysplastic syndrome has changed. Formerly, the diagnosis of AML required that 30 percent of abnormal, or blast, cells be present. Now, the diagnosis is made when 20 percent of cells are abnormal.

"This is a significant difference," said Bloomfield. "Earlier, a patient with 20 to 30 percent blasts was not said to have leukemia." Instead, they were categorized as having 'refractory anemia with excess blasts in transformation,' and as a result, they received minimal treatment.

"That has now been eliminated," said Bloomfield. "Many of us felt that these patients really had leukemia, but that we had found it at an earlier stage of the disease. Now someone with 20 percent blasts will be treated with high-dose chemotherapy for acute leukemia."

The new WHO cla
'"/>

Contact: Clara Bloomfield
Bloomfield-1@medctr.osu.edu
614-293-7518
Ohio State University
2-Mar-2000


Page: 1 2 3

Related medicine news :

1. Hormonal treatment improves survival in high-risk prostate cancer patients
2. International breast cancer prevention study launches in the United States and Canada
3. Unexpected benefit seen in treating HER-2 breast cancer with new preoperative drug combo
4. Cultural and social factors influence prostate cancer treatment
5. Primary care office strategies may increase colon cancer screening
6. Benefits of lung cancer screening with CT questioned
7. Three-year cervical cancer screening recommendations may be applicable for certain women with HIV
8. Study finds majority of women willing to accept cervical cancer vaccine for self and children
9. African-American women with endometrial cancer have more aggressive cancer than Caucasian women
10. Employment prospects good for most cancer survivors -- but not all
11. New colorectal cancer screening recommendations for African Americans

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/19/2019)... ... April 19, 2019 , ... According to the Environmental Working ... comes with pesticide residue. Pesticides are sprayed on produce to repel insects, but they ... make up that thin, waxy layer that covers the skin of most produce foods ...
(Date:4/19/2019)... ... April 18, 2019 , ... Residents in long-term-care nursing facilities were ... This is according to a study of U.S. men and women led ... the Brandman Research Institute (BRI) . The quality assurance study examined the high ...
(Date:4/18/2019)... ... 18, 2019 , ... Catalent, a global leader in clinical ... Clinical Supplies Group (GCSG) 2019 US Annual Conference at the Hyatt Regency Hill ... 2019. , Erin Vlack, Project Manager, will present a workshop titled “Bridging the ...
(Date:4/18/2019)... Vt. (PRWEB) , ... April 18, 2019 , ... ... Vermont’s captive regulation in a variety of areas. This year’s bill proposed several ... and improvements to the statute governing group captive investments. The many enhancements included ...
(Date:4/18/2019)... ... April 18, 2019 , ... ... provider for their care. Through the rise of online review sites and healthcare-related ... interaction and transparency when making important purchasing decisions online. In order to elevate ...
Breaking Medicine News(10 mins):
(Date:4/17/2019)... ... 17, 2019 , ... Clinical trials of new cancer treatments have historically focused ... on. With advances in medical oncology and genomic characterization of tumors, we are now ... by conducting “basket trials.” This ability has created a paradigm shift in oncology trials. ...
(Date:4/17/2019)... MALDEN, Mass. (PRWEB) , ... April 17, 2019 ... ... Mark McFarland completed his 50th case using NanoFUSE Biologics. The operation took place ... Dr. McFarland performed a posterior lumbar interbody fusion and removal of hardware on ...
(Date:4/17/2019)... NEW YORK (PRWEB) , ... April 17, 2019 , ... ... Pink Bag Event® at Barclays Center on Wednesday, April 3rd. Barclays Center, ... of Brooklyn, NY. UBCF thanks Brett Yormark, CEO of BSE Global, which operates and ...
Breaking Medicine Technology:
Cached News: